Presidential address

Raju Sharma

Thank you, Dr. Mohanan for the heart warming introduction and thank you to the dignitaries on the dais and off the dais for your benevolent presence.

At the outset I would like to congratulate Team Chandigarh IRIA 2019 for organizing this successful and simply sublime conference for our radiology fraternity.

Now, I would like to extend my earnest gratitude to my team, my supporters, and above all the association for electing me and bestowing me with honor of becoming the President of this illustrious association. I thank all office bearers for their staunch support and past presidents for their guidance and blessings.

It truly is a privilege to become the President of the association of the most challenging and dynamic medical branches of our time, a branch which forms the crux of clinical diagnosis, a branch which is the frontrunner in technological facets, and a branch which constitutes the creamiest of folks and the most intellectual minds of not only medicine but also of the world. It is a genuinely humbling moment for me and I hope to live up to my promises, and more importantly to your expectations.

The members of this fraternity are my family and I want to make a dream home, that is, a dream association for all of us, where ideas, academia, and leadership will flourish and thrive, a place which will be a haven for radiologists and radiology.

With your support, during my presidential administration and tenure, I would like to accomplish feats for our association which shall take it to new heights. The main motives during my presidency will be unity, expansion, and dominance of our association. And to achieve the same, my agenda shall comprise the following things among others:

Publication History

Article published online:
23 July 2021

• References

• 1 Taghizadeh Sarvestani R, Moradveisi B, Kompany F, Ghaderi E. Correlation between heart and liver iron levels measured by MRI T2* and serum ferritin in patients with β-thalassemia major. Int J Pediatr 2016; 4: 1559-67
• 2 Vichinsky EP. Changing patterns of thalassemia worldwide. Ann N Y Acad Sci 2005; 1054: 18-24
• 3 Wood JC, Origa R, Agus A, Matta G, Coates TD, Galanello R. Onset of Cardiac iron loading in pediatric patients with thalassemia major. Haematologica 2008; 93: 917-20
• 4 Zurlo MG, De Stefano P, Borgna-Pignatti C, Di Palma A, Piga A, Melevendi C. et al. Survival and causes of death in thalassaemia major. Lancet 1989; 2: 27-30
• 5 Chouliaras G, Berdoukas V, Ladis V, Kattamis A, Chatziliami A, Fragodimitri C. et al. Impact of magnetic resonance imaging on cardiac mortality in thalassaemia major. J Magn Reson Imaging 2011; 34: 565-9
• 6 Hekmatnia A, Radmard AR, Rahmani AA, Adibi A, Khademi H. Magnetic resonance imaging signal reduction may precede volume loss in the pituitary gland of transfusion-dependent beta- thalassemic patients. Acta Radiol 2010; 51: 71-7
• 7 Tanner MA, Galanello R, Dessi C, Westwood MA, Smith GC, Nair SV. et al. Myocardial iron loading in patients with thalassemia major on deferoxamine chelation. J Cardiovasc Magn Reson 2006; 8: 543-7
• 8 Aessopos A, Fragodimitri C, Karabatsos F, Hatziliami A, Yousef J, Giakoumis A. et al. Cardiac magnetic resonance imaging R2* assessments and analysis of historical parameters in patients with transfusion-dependent thalassemia. Haematologica 2007; 92: 131-2
• 9 Gandon Y, Olivié D, Guyader D, Aubé C, Oberti F, Sebille V. et al. Non-invasive assessment of hepatic iron stores by MRI. Lancet 2004; 363: 357-62
• 10 Gandon Y. On-line liver iron quantification. Available from: https://imagemed.univ-rennes1.fr/en/mrquantif/online_quantif.php. [Last accessed on 2017 Mar 25]
• 11 Fahmy HS, Khater NH, El-Shahat HM, Madani AA, El Hadidy SS. Reassessing the value of MRI T2* in evaluation of hepatic and myocardial iron concentration: An institutional study. Egypt J Radiol Nucl Med 2015; 46: 1085-90
• 12 Voskaridou E. Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassemia and sickle cell disease. Br J Haematol 2004; 126: 736-42
• 13 Fischer R, Longo F, Nielsen P, Engelhardt R, Hider RC, Piga A. Monitoring long term efficacy of iron chelation therapy by deferiprone and deferoxamine in patients with beta-thalassemia major application SQUID biomagnetic liver susceptometry. Br J Haematol 2003; 121: 938-48
• 14 Modell B, Khan M, Darlison M, Westwood MA, Ingram D, Pennell DJ. Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2008; 10: 42
• 15 Wood JC. Impact of iron assessment by MRI. Hematology Am Soc Hematol Educ Program 2011; 443-50
• 16 Anderson LJ, Holden S, Davis B, Prescott E, Charrier CC, Bunce NH. et al. Cardiovascular T2 star (T2*) magnetic resonance for early diagnosis of myocardial iron overload. Eur Heart J 22: 2171-9
• 17 Westwood M, Anderson LJ, Firmin DN, Gatehouse PD, Charrier CC, Wonke B. et al. A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial overload. J Magn Reson Imaging 2003; 18: 33-9
• 18 Buja LM, Roberts WC. Iron in the heart: Etiology and clinical significance. Am J Med 1971; 51: 209-21
• 19 Kirk P, Roughton M, Porter JB, Walker JM, Tanner MA, Patel J. et al. Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major. Circulation 2009; 120: 1961-8
• 20 Pepe A, Meloni A, Rossi G, Cuccia L, D'Ascola GD, Santodirocco M. et al. Cardiac and hepatic iron and ejection fraction in thalassemia major: Multicentre prospective comparison of combined deferiprone and deferoxamine therapy against deferiprone or deferoxamine monotherapy. J Cardiovasc Magn Reson 2013; 15: 1
• 21 Christoforidis A, Haritandi A, Tsitouridis I, Tsatra I, Tsantali H, Karyda S. et al. Correlative study of iron accumulation in liver, myocardium and pituitary assessed with MRI in young thalassemic patients. J Pediatr Hematol Oncol 2006; 28: 311-5
• 22 Eghbali AMD. Association between serum ferritin level, cardiac and hepatic T2-star MRI in patients with major B- thalassemia. Iranian J Pediatr Hematolo Oncol 2014; 4: 17-21
• 23 Mandal S, Sodhi KS, Bansal D, Sinha A, Bhatia A, Trehan A. et al. MRI for quantification of liver and cardiac iron in thalassemia major patients: Pilot study in Indian population. Indian J Pediatr 2017; 84: 276-82
• 24 Tziomalos K, Perifanis V. Liver iron content determination by magnetic resonance imaging. World J Gastroenterol 2010; 16: 1587-97
• 25 Noetzli LJ, Carson SM, Nord AS, Coates TD, Wood JC. Longitudinal analysis of heart and liver iron in thalassemia major. Blood 2008; 112: 2973-8
• 26 Olivieri NF, Nathan DG, MacMillan JH, Wayne AS, Liu PP, McGee A. et al. Survival in medically treated patients with homozygous β-thalassemia. N Eng J Med 1994; 331: 574-8
• 27 Murphy CJ, Oudit GY. Iron-overload cardiomyopathy: Pathophysiology, diagnosis, and treatment. J Cardiac Failure 2010; 11: 888-900
• 28 Kayrak M, Acar K, Gul EE, Ozbek O, Abdulhalikov T, Sonmez O. et al. The association between myocardial iron load and ventricular repolarization parameters in asymptomatic beta-thalassemia patients. Adv Hematol 2012; 2012: 1705-10
• 29 Magri D, Sciomer S, Fedele F, Gualdi G, Casciani E, Pugliese P. et al. Increased QT variability in young asymptomatic patients with β-thalassemia major. Eur J Haematol 2007; 79: 322-9
• 30 Detterich J, Noetzli L, Dorey F, Bar-Cohen Y, Harmatz P, Coates T. et al. Electrocardiographic consequences of cardiac iron overload in thalassemia major. Am J Hematol 2012; 87: 139-44
• 31 Scheiber-Mojdehkar B, Zimmermann I, Dresow B, Goldenberg H. Differential response of non- transferrin bound iron uptake in rat liver cells on long-term and short-term treatment with iron. J Hepatol 1999; 31: 61-70